These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9768243)

  • 1. [Effectiveness of VA-MENGOC-BC in children from 0 to 5 years of age in Cuba. First year of observation].
    Rico Cordeiro O; Bravo González JR; Díaz González M
    Rev Cubana Med Trop; 1994; 46(2):94-8. PubMed ID: 9768243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The post-licensing efficacy of VA-MENGOC-BC in children under 6 in Holguín, Cuba. The first year of observation].
    Rico Cordeiro O; Pereira Colls C; Fernández AA
    Rev Cubana Med Trop; 1995; 47(1):59-64. PubMed ID: 9805070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Meningococcal disease and VA-MENGOC BC in minors less than 1 year of age. Cuba, 1983 to 1991].
    Rico Cordeiro O; Jiménez Barreras R; Pereira Colls C
    Rev Cubana Med Trop; 1996; 48(1):34-9. PubMed ID: 9768267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
    Noronha CP; Struchiner CJ; Halloran ME
    Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hyperferremic mouse model for the evaluation of the effectiveness of VA-MENGOC-BC against Neisseria meningitidis B clinical isolates.
    Sifontes S; Infante JF; Pérez P; Caro E; Sierra G; Campa C
    Arch Med Res; 1997; 28(1):41-5. PubMed ID: 9078586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [VA-MENGOC-BC vaccine: its impact on meningococcal disease in children 1-4 years old].
    Pérez Rodríguez A; Meneses FO
    Rev Cubana Med Trop; 1999; 51(3):189-93. PubMed ID: 10887587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Observation on the epidemiologic efficacy for 9 years on epidemic meningococcal polysaccharide vaccine of group A by district immunization method].
    Ma Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Apr; 12(2):69-71. PubMed ID: 2065343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiological impact of antimeningococcal B vaccination in Cuba.
    Rodriguez AP; Dickinson F; Baly A; Martinez R
    Mem Inst Oswaldo Cruz; 1999; 94(4):433-40. PubMed ID: 10445998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meningococcal disease in the City of Havana before and after vaccination].
    Rodríguez AP; Serpa IM; García M
    Rev Cubana Med Trop; 2002; 54(2):106-12. PubMed ID: 15849936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a mass immunization campaign against serogroup C meningococcus in the Province of Quebec, Canada.
    De Wals P; Dionne M; Douville-Fradet M; Boulianne N; Drapeau J; De Serres G
    Bull World Health Organ; 1996; 74(4):407-11. PubMed ID: 8823963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evolution of meningococcal infection among infant population in the autonomous community of Valencia (1996-2000). Effectiveness of A+C meningococcal vaccination].
    Goicoechea Sáez M; Fullana Montoro AM; Momparler Carrasco P; Redondo Gallego MJ; Brines Solanes J; Bueno Cañigral FJ
    Rev Esp Salud Publica; 2003; 77(1):125-42. PubMed ID: 12696392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
    Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
    Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years.
    Galloway Y; Stehr-Green P; McNicholas A; O'Hallahan J
    Int J Epidemiol; 2009 Apr; 38(2):413-8. PubMed ID: 18988650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evolution of meningococcal disease in the community of Madrid. Effectiveness of antimeningococcal A+C vaccination].
    Gutiérrez Rodríguez MA; Ramírez Fernández R; García Gutiérrez J; Moreno Civantos A; Hernando García M; Arce Arnáez A; Sendra Gutiérrez JM; Bueno Vallejos R
    Rev Esp Salud Publica; 2000; 74(4):397-403. PubMed ID: 11031849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of the anti-meningococcal vaccine VA-MENGO-BC in the first year of life of Cuban children, 1997-2008].
    Pérez Rodríguez A; Dickinson Meneses F; Rodríguez Ortega M
    Rev Cubana Med Trop; 2011; 63(2):155-60. PubMed ID: 23437524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term protection in children with meningococcal C conjugate vaccination: lessons learned.
    Borrow R; Miller E
    Expert Rev Vaccines; 2006 Dec; 5(6):851-7. PubMed ID: 17184222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of an immunization campaign with group A and C meningococcal polysaccharide vaccine in controlling an outbreak of group C meningococcal disease].
    Gong J; Li CY; Dong BQ; Huang JZ; Quan Y; Lu WZ; Luo CH; Mao WC; Liao HZ; Fang JS; Cui XL; Xie GL; Wu XH; Lan RW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):552-5. PubMed ID: 19040035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of previous immunisation on the incidence of meningococcal disease during an outbreak in a Sahelian area of Senegal.
    Chippaux JP; Diallo A; Marra A; Etard JF
    Vaccine; 2007 Feb; 25(10):1712-8. PubMed ID: 17240492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the vaccination campaign in Cantabria 2 years of epidemiological evolution].
    González de Aledo A; García Merino J
    Rev Esp Salud Publica; 2000; 74(4):405-11. PubMed ID: 11031850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Haemophilus influenzae type b invasive disease and meningococcal disease: incidence and characteristics in Barcelona, 1994-1995. Work Group IMS-IUSPC for Surveillance and Control of Meningitis].
    Beni C; Caylà JA; Jansà JM; Maldonado R; Pañella H; Rajmil L; Villalbí JR
    Med Clin (Barc); 1999 Jan; 112(1):1-4. PubMed ID: 10027177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.